Consumer-perceived risks and choices about pharmaceuticals in the environment: a cross-sectional study
Simone Dohle1, Victoria E A Campbell, Joseph L Arvai
1Institute for Environmental Decisions, ETH Zurich, Zurich, Switzerland. sdohle@ethz.ch
Summary
Public awareness of pharmaceutical pollution risks is low. People prioritize drug effectiveness for severe illnesses but consider environmental impact for less serious conditions, influencing policy support.
Area of Science:
- Environmental Science
- Public Health
- Risk Perception
Background:
- Growing concern over pharmaceutical pollution from human medicine and agriculture impacting ecosystems.
- Limited understanding of public awareness regarding the environmentaldetrimental effects of pharmaceuticals.
- This study investigates public perception and decision-making concerning environmental risks of pharmaceuticals.
Purpose of the Study:
- To assess public risk perception of pharmaceutical pollution.
- To evaluate public choices regarding pharmaceuticals considering environmental health tradeoffs.
- To gauge public support for environmental policies on drug regulation.
Main Methods:
- Survey of a representative U.S. population sample (N=640).
- Utilized a hypothetical choice task assessing human vs. environmental health tradeoffs.
- Examined public support for environmental policies related to drug regulation.
Main Results:
- High support for policies limiting agricultural antibiotic use.
- Willingness to consider environmental impact for less severe human diseases.
- Drug effectiveness was paramount for severe disease treatment decisions.
Conclusions:
- Environmental impact is often overlooked for severe disease treatments due to affective decision-making.
- Public willingness to balance health and environmental concerns increases for less severe health risks.
- Findings suggest nuanced public attitudes towards pharmaceutical environmental risks.
Related Concept Videos
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:36Types of Toxins
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).